SWKH - SWK Holdings Corp

16.81
0.160   0.952%

Share volume: 3,824
Last Updated: 03-06-2026
Banking/Business Credit Institutions: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$16.65
0.16
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
66%
Profitability 70%
Dept financing 25%
Liquidity 75%
Performance 69%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.00%
1 Month
-2.61%
3 Months
-1.00%
6 Months
14.20%
1 Year
2.13%
2 Year
3.32%
Key data
Stock price
$16.81
P/E Ratio 
7.78
DAY RANGE
$16.74 - $16.86
EPS 
$1.77
52 WEEK RANGE
$13.17 - $20.49
52 WEEK CHANGE
$2.13
MARKET CAP 
176.745 M
YIELD 
27.49%
SHARES OUTSTANDING 
12.096 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
0.14
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$10,637
AVERAGE 30 VOLUME 
$7,191
Company detail
CEO: Joe D. Staggs
Region: US
Website: swkhold.com
Employees: 40
IPO year: 2006
Issue type: Common Stock
Market: XNAS
Industry: Banking/Business Credit Institutions
Sector: Finance, Insurance, And Real Estate

SWK Holdings Corporation provides customized financing solutions to a range of life science companies. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endocrine disease. The company was founded in 1996 and is headquartered in Dallas, Texas.

Recent news